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Abstract
 
Previous studies have indicated that the E2A gene products are required to initiate B lineage
development. Here, we demonstrate that E2A
 
   
 
 B cells that express an autoreactive B cell
receptor fail to mature due in part to an inability to activate secondary immunoglobulin (Ig)
light chain gene rearrangement. Both RAG1/2 gene expression and RS deletion are severely
defective in E2A
 
   
 
 mice. Additionally, we demonstrate that E2A
 
   
 
 mice show an increase in
the proportion of marginal zone B cells with a concomitant decrease in the proportion of fol-
licular B cells. In contrast, Id3-deficient splenocytes show a decline in the proportion of marginal
zone B cells. Based on these observations, we propose that E-protein activity regulates secondary
Ig gene rearrangement at the immature B cell stage and contributes to cell fate determination of
marginal zone B cells. Additionally, we propose a model in which E-proteins enforce the develop-
mental checkpoint at the immature B cell stage.
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Introduction
 
B cell developmental progression requires the assembly of
Ig genes from germline gene segments (1, 2, 3). In pro–B
cells, Ig heavy chain (IgH) gene rearrangement is initiated
by the joining of D and J segments, followed by V(D)J
rearrangement. Once a VDJ rearrangement has produced
an in-frame joining of V, D, and J DNA segments, the
heavy chain together with surrogate light chains is assembled
into a signaling complex called the pre–B cell receptor
(BCR). Signals emanating from the pre-BCR inhibit further
recombinase activity, preventing continued IgH chain gene
rearrangement (4, 5). B lineage cells undergo rapid prolifer-
ation followed by G1 arrest, reactivation of RAG expression,
and initiation of Ig light chain (IgL) gene rearrangement. A
productive IgL gene rearrangement permits surface Ig expres-
sion and developmental progression toward B cell maturity
(6). Immature B cells expressing a unique IgH and IgL
gene product are tested for reactivity against self-antigens.
At this stage, autoreactive B cells are either deleted, anergized,
or modified by continued IgL gene rearrangement, termed
receptor editing (7–10). During the receptor editing process,
secondary light chain gene rearrangements replace existing
IgLs, generating receptors with altered specificities. B cells
develop to maturity if the replacement generates a nonself-
reactive receptor (11–13).
Several transcription factors that regulate the early stages of
B cell development have been identified. Among these are
the E2A proteins, early B cell factor (EBF) and Pax-5 (14–
17). Both E2A and EBF null mutant mice are arrested at a
stage before the onset of IgH DJ rearrangement (14, 15, 17).
B cell development in Pax-5 null mutant mice is arrested at
the pro–B cell stage (16). The E2A gene encodes for two
proteins, designated E12 and E47, which arise by differential
splicing. Both E12 and E47 are members of the class I helix-
loop-helix proteins, also named E-proteins (18). The E2A
proteins are required for cell survival at the pro–B cell stage
and act in concert with EBF to regulate 
 
 
 
5 and RAG gene
expression (19–21). In vitro experiments have suggested that
E2A and EBF also have the ability to promote IgH DJ and
Ig
 
 
 
 light chain gene rearrangement (22, 23).
Here, we have examined the expression and function of
the E2A proteins beyond the pro–B cell stage. E47 protein
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levels are high in pro–B cells, but are lowered upon matur-
ing through the pre-BCR checkpoint. E47 levels are ele-
vated again at the pre–B cell stage and remain high until the
cells reach the mature B cell compartment. We show that
the E2A proteins are required to regulate secondary Ig gene
rearrangements in B cells that express an autoreactive BCR,
due in part to activate RAG expression and to induce RS
deletion. Finally, our observations demonstrate that the E2A
proteins and their antagonist, Id3, modulate the develop-
mental progression of immature B lineage cells and regulate
cell fate determination of marginal zone B cells.
 
Materials and Methods
 
Mouse Strains.
 
C57BL/6 E2A and Id3 mutant mice have
been described previously (14, 15, 24). 3-83 BCR transgenic
B10.D2nSn/J mice have been described previously (8). All mice
were analyzed between 6 and 16 wk of age.
 
Flow Cytometric Analysis.
 
Cells were stained in suspension
in 0.1 ml FACS
 
®
 
 buffer (1
 
 
 
 PBS, 0.5% FCS plus 0.02% so-
dium azide) plus the indicated antibodies on ice for 15 min.
Cells stained with biotinylated antibodies were washed once in
2 ml FACS
 
®
 
 buffer and incubated with streptavidin-allophy-
cocyanin for 15 min on ice. After staining, cells were washed,
fixed in 1
 
 
 
 PBS plus 1% formaldehyde and analyzed on a
FACScan™ or FACScalibur™ (Becton Dickinson). Cells were
gated on the basis of forward side scatter. All antibodies, ex-
cept the anti–3-83 antibody (S23), were obtained from BD
Biosciences. For analysis of intracellular E47 expression, cells
were first stained for surface antigens, washed in PBS plus 5%
FCS, fixed in 1% paraformaldehyde, permeabilized with Tween-
20, and stained with G127-32 (anti–E47-PE) as described pre-
viously (25).
Figure 1. Expression of E47
in B lineage subsets derived from
the bone marrow and spleen
from E2A wild-type and    
mice. Bone marrow or spleen
cells were stained with the indi-
cated antibodies and analyzed for
E47 expression by flow cytometry.
(A) E47 expression in developing
B lineage cells. Numbered gates
indicate the subpopulations ex-
amined for E47 expression. Histo-
grams show E47 expression levels
in each subset using an E47-
specific  antibody. Shaded areas
indicate E47 expression in wild-
type B cells. Solid lines indicate
E47 expression in E2A /  cells.
Dotted lines indicate isotype con-
trol staining. (B) B220 CD43 
pro–B cells were subdivided based
on HSA expression and analyzed
for E47 expression. Histograms
depict the E47 staining in wild-
type (shaded areas), E2A / 
(solid lines), and isotype control
(dotted lines) mice within the
pro–B cell compartment. (C) E47
expression in large and small
pre–B cells. Bone marrow cells
were stained for the presence of
B220 and CD25 and further sub-
divided on the basis of cell size.
Histograms show the expression
of E47 in large cycling (LC) versus
small resting (SR) pre–B cells. His-
tograms depict E47 expression in
wild-type (shaded areas), E2A   
(solid lines), and isotype control
staining (dotted lines) mice in
each gated subset. (D) E47 ex-
pression in peripheral B cells.
Splenocytes were stained for the
presence of B220, IgM, and IgD.
Histograms depict E47 expression
in wild-type (shaded areas),
E2A    (solid lines), and isotype
control staining (dotted lines)
mice in each gated subset. 
Quong et al.
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Rag, 
 
 
 
o
 
 Germline Transcript, IgL Rearrangement, and RS Deletion
Analyses.
 
Bone marrow B220
 
 
 
 cells were purified using Mini-
MACS LS columns (Miltenyi Biotec). RNA was prepared via
RNeasy (QIAGEN). Synthesis of cDNA was performed using
oligo-dT and Superscript II reverse transcriptase. The template
for RT-PCR was cDNA diluted three- or fivefold in water for
each serial dilution point. Genomic DNA was prepared by
proteinase K treatment. PCR primer sequences used were as
follows: Rag1, Rag2, and B29 have been described previously
(10,  21); 
 
 
 
o
 
for, 5
 
 
 
-CAGTGAGGAGGGTTTTTGTACAGC-
CAGACAG-3
 
 
 
; J
 
 
 
2rev, 5
 
 
 
-TTTCCAGCTTGGTCCCCCCTC-
CGAA-3
 
 
 
 (26); V
 
 
 
consFor, 5
 
 
 
-GGCTGCAGSTTCAGTGG-
CAGTGGRTCWGGRAC-3
 
 
 
; J
 
 
 
1Rev, 5
 
 
 
-GCCACAGACAT-
AGACAACGGAAGAA-3
 
 
 
 (26); V
 
 
 
leaderFor, 5
 
 
 
-GTTTGTG-
AATTATGGCCTGGAT-3
 
 
 
; J
 
 
 
1Rev, 5
 
 
 
-CTAGGACAGT-
CAGTTTGGTTCC-3
 
 
 
 (27); V
 
 
 
D, 5
 
 
 
-GGCTGCAGSTTC-
AGTGGCAGTGGRTCWGGRAC-3
 
 
 
; and RS2, 5
 
 
 
-CTGC-
CCACACGACTCCTTCAGGCAGACG-3
 
 
 
 (28). Induction of
RS deletion in vitro in the BOSC 23 embryonic kidney cell line
was performed as described previously (23). Primer sequences
used were as follows: V
 
 
 
1, 5
 
 
 
-GTAGGAGACAGAGTCAC-
CATCACT-3
 
 
 
; and Kde, 5
 
 
 
-CCCTTCATAGACCCTTCAG-
GCAC-3
 
 
 
.
 
Results
 
Dynamic Pattern of E47 Expression in B Lineage Develop-
ment.
 
Previous data using cell sorting, immunofluores-
cence, and Western blotting have indicated that E47 levels
are expressed in pro–B and pre–B cells but decreased in
immature and mature B lineage cells (29). To examine the
expression of E47 more precisely in primary B lineage cells,
lymphocytes were isolated from the bone marrow of wild-
type and E2A
 
   
 
 mice and stained for the presence of E47
using flow cytometric analysis of permeabilized cells (Fig.
1). The expression of E47 was examined in five develop-
mental B cell compartments as defined by the expression of
B220, CD43, IgM, and IgD. The pro–B cell stage can
be characterized by the expression of B220 and CD43.
B220
 
 
 
CD43
 
 
 
 B cells showed two distinct populations ex-
pressing different levels of E47 (Fig. 1 A). Interestingly,
E47 expression was variegated in the pre–B cell compart-
ment (Fig. 1 A, B220
 
 
 
CD43
 
 
 
IgM
 
 
 
). The expression level
of E47 was high within virtually all B220
 
 
 
 IgMlo IgD
 
 
 
cells, but was decreased significantly in the IgMhi and
IgM
 
 
 
IgD
 
 
 
 subsets (Fig. 1 A).
Figure 2. B cell development in E2A /  mice is perturbed.
(A) Comparison of the pro–B, pre–B, and immature B cell com-
partments from wild-type and E2A /  mice. Cells were isolated
from bone marrow and analyzed for the presence of B220, c-kit,
CD25, IgM, and IgD by flow cytometric analysis. Numbers reflect
the percentage of cells in each gated population. (B) Ig  expression
is perturbed in E2A /   mice. Splenocytes isolated from E2A
wild-type and E2A /  mice were stained for surface expression of
B220 and Ig  and analyzed by flow cytometry. Representative
dot plots are shown (top). (bottom) Total number of B220  cells
(left). The percentage and total number of    cells, respectively
(middle and right). (C) Flow cytometric analysis of B220 and Ig 
expression in bone marrow from E2A wild-type and E2A / 
mice as described in B. 
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To further define the stage in which E47 is increased at
the pro–B cell compartment, cells were stained for the
presence of B220, CD43, and heat-stable antigen (HSA).
HSA negative cells lack significant levels of IgH DJ rear-
rangements, whereas most cells that express HSA have un-
dergone IgH DJ rearrangements. The majority of the pro–
B cells that express HSA express relatively high levels of
E47, whereas the HSA null cells contained low levels of
E47 (Fig. 1 B). These observations indicate that E47 ex-
pression is elevated at a stage in which B cells become
committed to the B cell lineage.
As aforementioned, E47 expression was heterogeneous
in the B220
 
 
 
CD43
 
 
 
IgM
 
 
 
 subset. To more precisely define
E47 expression in this population, cells were stained for the
expression of B220 and CD25 and further analyzed based
on cell size (Fig. 1 C). E47 expression was uniformly high
in the small resting pre–B cell population. In contrast, the
majority of the large cycling cells expressed relatively low
levels of E47 (Fig. 1 C). Interestingly, E2A
 
   
 
 cells showed
a large fraction of cycling cells as compared with wild-type
cells (Fig. 1 C). Additionally, we note that the proportion
of cells that express significant levels of E47 in E2A
 
   
 
 cells
was significantly decreased in the cycling populations (Fig.
1 C). Together, these data suggest that E47 levels tran-
siently decline in response to pre-BCR signaling. Once the
cells reach the pre–B cell stage, E47 expression is elevated
to levels similar to that at the pro–B cell stage.
To examine E47 expression in peripheral B lineage cells,
splenocytes were stained for the presence of IgM and IgD,
permeabilized, stained, and analyzed for E47 expression by
flow cytometry. As observed in the bone marrow, transi-
tional B cells (IgMhi IgDint) displayed a marked decrease
in E47 protein levels as compared with immature B cells
(Fig. 1 D, IgMlo IgD
 
 
 
). The mature B cell compartment
(IgM
 
 
 
IgD
 
 
 
) virtually lacked E47 expression (Fig. 1 D).
Thus, E47 levels decline as cells mature into the IgM
 
 
 
IgD
 
 
 
cell stage.
In summary, these data indicate that the pattern of E47
expression is dynamic throughout B lineage development.
E47 expression is induced at the point of B lineage com-
mitment, lowered at the pre-BCR checkpoint, elevated in
small resting pre–B cells, lowered in transitional B cells, and
barely detectable in mature B cells.
 
E2A Heterozygosity Perturbs B Lineage Development.
 
Because
B cell development in E2A
 
   
 
 mice is blocked at a stage
before the onset of IgH chain gene rearrangement, we ex-
amined E2A
 
   
 
 mice for abnormalities beyond the pro–B
cell stage. Bone marrow cells were isolated from wild-type
and E2A
 
   
 
 mice and analyzed by flow cytometry. The
pro–B cell population (B220
 
 
 
c-kit
 
 
 
) was not significantly
altered in E2A
 
   
 
 mice as compared with wild-type mice
(Fig. 2 A). However, the fraction of pre–B cells (B220
 
 
 
CD25
 
 
 
) was reduced almost twofold in E2A
 
   
 
 mice (Fig.
2 A). Similarly, the IgM
 
 
 
IgD
 
 
 
 population was significantly
decreased in E2A heterozygous mice (Fig. 2 A). The frac-
tion of IgM
 
 
 
IgD
 
 
 
 mature B cells was elevated in the bone
marrow of E2A
 
   
 
 mice (Fig. 2 A).
In vitro and in vivo observations have indicated that the
E2A proteins bind to sites present in the Ig
 
 
 
 and 
 
 
 
 enhanc-
ers (30–32). Furthermore, overexpression of E2A in con-
junction with the RAG gene products readily activates Ig
 
 
 
and 
 
 
 
 gene rearrangement in embryonic kidney cells (23,
33). These data suggested that the E2A proteins function in
B cell development by promoting accessibility of the re-
combination signal sequences to the recombination ma-
chinery. These findings also raised the possibility that in
immature B cells, the E2A proteins function to promote
secondary IgL gene rearrangements. As a first approach to
address this possibility, we examined the expression of Ig
 
 
 
on mature B cells derived from wild-type and E2A
 
   
 
mice. Splenocytes were isolated and examined for the ex-
pression of B220 and Ig
 
 
 
 (Fig. 2 B). The total number of
B220
 
 
 
 cells was slightly reduced in E2A
 
   
 
 mice as com-
pared with wild-type mice (Fig. 2 B). Interestingly, the
fraction of B cells that expressed Ig  was significantly re-
duced in E2A    mice (Fig. 2 B). On average, the total
number of Ig -expressing cells was threefold lower in
E2A    mice as compared with wild-type mice (Fig. 2 B).
To determine whether the proportion of Ig -expressing
cells in the bone marrow was also altered in E2A    mice,
bone marrow cells were isolated and analyzed for the ex-
pression of Ig . As expected, the proportion and the total
number of Ig  positive cells were significantly lower in the
bone marrow of E2A heterozygous mice (Fig. 2 C). These
data demonstrate that E2A dosage regulates the  /  ratio
and establish a role for E2A proteins in B cell development
beyond the pro–B cell stage.
Self-antigen Promotes B Cell Depletion in E2A Heterozygous
Mice. The observation that E2A heterozygosity results in
decreased Ig  usage suggests a potential role for E2A in
promoting secondary IgL chain gene rearrangements. To
test this possibility, E2A    mice were crossed with mice
that carry the 3-83 transgene (8). 3-83 B cells express a
BCR of defined specificity that recognizes epitopes present
on the H-2Kk,b major histocompatibility complex antigen.
In a nondeleting H-2Kd background, 3-83 mice contain a
virtual monoclonal B cell compartment expressing the 3-83
transgene. However, in the presence of autoantigen, in the
H-2Kb background, B cells undergo receptor editing. Such
B cells contain secondary Ig  or Ig  rearrangements and
lack 3-83 reactivity (10). Consistent with previous observa-
tions, peripheral B cells from 3-83 transgenic mice in both
nonediting and editing backgrounds were readily detect-
able (Fig. 3, A and C, left and middle, respectively). In
contrast, mature B cells were virtually absent in splenocyte
populations derived from E2A    mice expressing the 3-83
transgene in the presence of self-antigen (Fig. 3, A and C;
right). As expected, the Ig /  ratio was severely affected in
the few B cells that developed in E2A    mice (Fig. 3, C
and D). We also examined whether E2A heterozygosity af-
fected allelic exclusion by staining with antibodies specific
for the endogenous Ig allotypes. Expression of the endoge-
nous IgH remained excluded by the presence of the 3-83
transgene, indicating that allelic exclusion was not affectedQuong et al. 1105
by E2A heterozygosity (Fig. 3 A, bottom). Additionally,
tolerance was maintained in E2A   ;3-83 mice because the
few B cells that did develop lacked 3-83 specificity (Fig. 3
B). Together, these data suggest that E2A heterozygosity
affects the ability of B lineage cells to undergo receptor ed-
iting in response to self-antigen.
RAG Gene Expression, Ig  and   Gene Rearrangement, and
RS Deletion Are Affected in E2A    B Lineage Cells. Because
proper receptor editing requires the expression of the RAG
gene products, we analyzed E2A   ;3-83 B cells for RAG
expression using mice carrying a transgene in which the
green fluorescent protein (GFP) coding sequence was in-
serted into the RAG2 locus (34). RAG-GFP mice were
crossed into E2A    mice carrying an autoreactive BCR
(3-83) and analyzed for GFP expression in B220 CD43 
cells. RAG expression as measured by fluorescence was de-
creased by a factor of approximately twofold in E2A   
cells carrying an autoreactive BCR (unpublished data). To
further analyze RAG transcript levels, RNA was isolated
from purified B220 CD43  bone marrow cells and ana-
lyzed by semi-quantitative RT-PCR (Fig. 4 A). As ex-
pected, both RAG-1 and RAG-2 transcripts were readily
detectable in mRNA derived from wild-type 3-83 trans-
genic B cells receiving the autoantigen signal. In contrast,
both RAG-1 and RAG-2 transcripts were severely reduced
in E2A   ;3-83 transgenic B cells. Interestingly, RAG-1
transcript levels were more perturbed than RAG-2 levels,
 25 versus 5-fold, respectively.
To determine whether E2A heterozygosity also affects Ig 
locus accessibility, the same samples were analyzed for  o germ-
line transcripts (Fig. 4 A). Both wild-type and E2A heterozy-
gous B cells express  o germline transcripts, albeit a modest
decrease was observed in the E2A    B cells (Fig. 4 A).
In vitro studies have indicated that the E2A proteins
have the ability to promote both Ig  and   VJ rearrange-
ment (23, 33). Chromatin immunoprecipitation assays have
demonstrated that the E2A proteins directly bind to sites
present in the Ig  light chain gene enhancer (32). Further-
Figure 3. The E2A proteins are required to promote developmental progression of autoreactive B lineage cells. (A) Flow cytometric analysis of spleno-
cytes from E2A wild-type 3-83 transgenic nonediting (B10D2) and editing (B/6:B10D2) mice and E2A / ;3-83 transgenic editing mice. (top) Staining
for the 3-83 transgenic heavy chain. (bottom) Expression of endogenous heavy chain. (left) B cells from E2A wild-type transgenic mice in a nonediting
B10D2 background. (middle and right) B cells from wild-type and E2A    transgenic mice in an editing background, respectively. Percentages in each
quadrant are indicated. (B) Tolerance is maintained in E2A / ;3-83 transgenic editing mice. Anti-idiotype staining for 3-83 BCR expression in spleno-
cytes from transgenic wild-type and E2A /  mice. (bold and solid lines) 3-83 expression in mature B cells from wild-type and E2A /  editing mice,
respectively. (dotted line) Positive 3-83 expression in B cells derived from transgenic mice in the nonediting background (B10D2). The percentage of
3-83 positive mature B cells is indicated. (C) Both secondary Ig  and Ig  rearrangements are perturbed in E2A / ;3-83 editing B cells. Splenocytes
derived from wild-type and E2A / ;3-83 mice as in A were analyzed for the expression of Ig  and IgDa by flow cytometry. As a comparison, the
percentage of Ig   B cells in a nonediting background is shown (left). (middle and right) The expression of secondary Ig  (top left) and secondary Ig 
(top right) chains on edited B cells from E2A wild-type and E2A /  mice. Percentages in each quadrant are indicated. (D) The Ig  versus Ig  ratio in B
lymphocytes derived from E2A wild-type and E2A / ;3-83 editing mice.E-Proteins Regulate B Cell Maturation 1106
more, it has been demonstrated that mice harboring a dele-
tion of the Ig  enhancers show a defect in the  /  ratio
similar to that observed here in E2A    B lineage cells (35).
These observations raised the possibility that E2A    B cells
failed to undergo receptor editing upon encountering self-
antigen because of an inability to undergo efficient IgL
gene rearrangement. To determine whether wild-type lev-
els of E2A are required to activate Ig  and   secondary re-
arrangements, DNA was isolated from purified B220 
bone marrow cells, and VJ rearrangements were analyzed
by PCR. As expected, in wild-type mice that carry the
3-38 BCR in the presence of self-antigen, secondary Ig 
and   rearrangements were readily detectable. In contrast,
both Ig  and   VJ rearrangements were severely impaired
in E2A    B lineage cells (Fig. 4 B). These data indicate
that secondary gene rearrangements involving the Ig  and
  loci are significantly affected in E2A    mice.
The observed skewing of the Ig /  ratio in E2A   
mice raised the possibility that Ig  rearrangement is partic-
ularly sensitive to E2A dosage. Secondary rearrangements
involving the Ig  locus are frequently preceded by deletion
of the Ig  enhancer and constant regions through a specific
rearrangement event involving an upstream RSS and the 3 
RS element, also named the  -deleting element. To deter-
mine whether RS deletion is affected in E2A   ;3-83 B
lymphocytes, DNA was isolated and analyzed for the pres-
ence of RS rearrangement. As expected, in wild-type B
cells, V-RS rearrangements were readily detectable (Fig. 4
C). In striking contrast, RS deletion was severely affected
in E2A   ;3-83 B cells (Fig. 4 C). Together, these data in-
dicate that E2A heterozygous B cells that express an au-
toreactive BCR are severely impaired in their ability to un-
dergo secondary IgL chain gene rearrangements.
Induction of RS Deletion by the Expression of E2A and
RAG1/2 in Nonlymphoid Cells. Because RS deletion is
perturbed in E2A    mice that carry the 3-83 transgene,
we considered the possibility that E2A proteins directly
regulate secondary IgL gene rearrangements by promoting
accessibility of the RSSs to the recombination machinery.
Previous data showed that the E2A proteins have the abil-
ity to regulate rearrangement of the light chain gene loci in
nonlymphoid cells (23, 27). However, it remained to be
determined whether the E2A proteins also have the ability
to activate RS deletion. Two distinct elements containing
an RSS involved in RS deletion are located in the human
Ig  locus (36). An isolated RSS is located between the
joining and constant regions, whereas another RSS, desig-
nated as the Kde element is located 3  of the constant re-
gion (Fig. 5 A). The Ig  enhancer and the constant region
are deleted upon rearrangements that involve the Kde ele-
ment (Fig. 5 A). To determine whether E2A proteins have
the ability to directly promote RS deletion, an embryonic
kidney cell line was transfected with expression vectors en-
coding either E12 or E47 and RAG1 and RAG2. 3 d after
transfection, DNA was harvested and analyzed by PCR for
RS deletion. As expected, neither E12 nor E47 alone had
the ability to promote RS deletion. Similarly, expression of
RAG1 and RAG2 by themselves did not promote V-Kde
joining (Fig. 5 B). In contrast, in the presence of RAG1
and -2, both E12 and E47 were able to activate RS dele-
tion upon overexpression (Fig. 5 B). To examine the na-
ture of the V-Kde joints, PCR products were isolated,
cloned, and analyzed by DNA sequencing (Fig. 5 C). The
RS deletions showed significant diversity. Distinct V  re-
gions interspersed throughout the human Ig  locus were
joined with the Kde element (Fig. 5 C). All RS rearrange-
ments showed nucleotide deletions of variable sizes (Fig. 5
C). As expected nucleotide additions were absent due to
Figure 4. RAG gene expression, IgL chain rearrangements, and RS
deletions are severely affected in E2A /  mice expressing a self-reactive
BCR. (A) RNA was isolated from purified B220 CD43  bone marrow
cells from E2A wild-type and E2A / ;3-83 transgenic mice. Fivefold
serial dilutions were analyzed for RAG1, RAG2, and  o germline tran-
scripts by RT-PCR. PCR products were separated by DNA gel electro-
phoresis and visualized by ethidium bromide staining. B29 transcripts are
shown to indicate equivalent loading and integrity of the cDNAs. (B) Geno-
mic DNA was isolated from purified B220  bone marrow cells, and
threefold serial dilutions were analyzed for secondary V -J 1 and V 1-J 1
rearrangements by PCR. PCR products were separated by DNA gel elec-
trophoresis and visualized by ethidium bromide staining. (left) Absence of
rearrangements in nonselecting (B10D2) background. (middle) Ig  and
Ig  rearrangements in E2A   ;3-83 B cells. (right) Ig  and Ig  rearrange-
ments in E2A / ;3-83 B cells. (bottom) Equivalent loading and DNA
integrity using actin primers. (C) RS deletion is perturbed in E2A / 
mice carrying an autoreactive BCR. DNA isolated from B220  bone
marrow cells was analyzed by PCR for RS deletion. PCR products were
analyzed by DNA gel electrophoresis and visualized by ethidium bromide
staining. (bottom) Equivalent DNA loading using primers specific for the
3-83 transgene.Quong et al. 1107
the lack of TdT expression. Together, these data demon-
strate that the E2A proteins have the ability to directly pro-
mote RS deletion.
E2A and Id3 Regulate Marginal Zone B Cell Develop-
ment. The decline in E47 expression in the transitional B
cell populations raised the possibility that lower levels of
E2A proteins promote the development toward a mature B
lineage phenotype. To determine whether lowering the
dosage of E2A promotes B cell maturation in the periph-
ery, we analyzed the splenic compartments from 3-83
transgenic mice in the nonediting background or hen egg
lysozyme (HEL) transgenic mice in the absence of selecting
antigen. E2A    BCR transgenic mice revealed strong re-
ductions in percentages of both IgMhi IgD /lo and IgMhi
IgD  transitional populations, whereas the proportion of
IgMlo IgD  mature B cells was elevated in E2A heterozy-
gous mice (Fig. 6, A and E). However, we note that non-
transgenic E2A    mice did not show an increase in the
fraction of IgMlo IgD  cells (Fig. 6 A).
Previous data have demonstrated that the antagonist he-
lix-loop-helix protein, Id3, is required to promote positive
selection in developing thymocytes by inactivating E2A/
HEB DNA binding activity (24). To determine whether a
deficiency in Id3 also perturbs B cell maturation, Id3   
mice were generated that carry the 3-83 transgene in a
nonediting H-2Kd background or the HEL transgene in
the absence of selecting antigen. Interestingly, the Id3 defi-
ciency led to a significant block at the transition from the
IgMhi IgD  to the IgMlo IgD  cell stage, resulting in a de-
cline of the percentages of mature B cells and in mice that
carried the 3-83 and HEL transgenes (Fig. 6, B and E).
Similarly, Id3-deficient mice that did not carry a BCR
transgene showed overall higher levels of IgM expression as
compared with wild-type B cells (Fig. 6 B).
To further delineate the developmental defects observed
in splenic B cells, transitional, marginal zone, and follicular
B cells were examined in wild-type, E2A   , and Id3-defi-
cient mice. In brief, splenocytes were stained for the ex-
pression of IgM, IgD, CD21, and CD23. T1 cells are char-
acterized by the expression of surface markers IgMhi IgD /
lo CD21 /lo CD23 ; T2 cells by the expression of IgMhi
IgDhi CD21hi CD23 ; marginal zone cells by the expres-
sion of IgMhi IgD /lo CD21hi CD23lo; and follicular
cells by the expression of IgMint IgDhi CD21int CD23hi
cells. E2A    splenocytes showed a significant increase in
the marginal zone B population with a correlative decrease
Figure 5. E12 and E47 act in concert with
RAG1 and RAG2 to promote RS deletion in an
embryonic kidney cell line, BOSC 23. (A) Sche-
matic representation of the Ig  locus. Triangles
represent the recombination signal sequences
(RSSs). The intron RSS and  de element are
indicated. (B) BOSC 23 cells were transfected
with expression vectors for E12, E47, RAG1,
and RAG2 and analyzed by PCR for V - de
recombination using V  and  de consensus
primers. PCR products were separated on a
1.5% agarose gel and visualized by staining with
ethidium bromide. The integrity of the DNA
was verified using PCR primers corresponding
to the human Abelson locus (bottom). (C) Di-
verse  repertoire of RS deletion generated in
nonlymphoid cells. PCR fragments obtained
from transfectants were isolated, cloned, and
sequenced. Sequences of the rearranged seg-
ments are indicated. Numbers reflect frequency
of identical clones.E-Proteins Regulate B Cell Maturation 1108
Figure 6. Marginal zone (MZ) B cell development is perturbed in E2A /  and Id3-deficient mice. (A) Flow cytometric analysis of IgM and IgD
expression of splenocytes derived from E2A wild-type and E2A /  mice carrying either 3-83 (nonautoreactive background B/6; B10D2) or HEL trans-
genes. The total number of cells per spleen is indicated, and the percentage of each gated population is shown. (B) Flow cytometric analysis of Id3-
deficient B lineage cells in the spleen as described in A. (C) Flow cytometric analysis of marginal zone B and follicular B cells from E2A wild-type and
E2A    splenocytes. MZ B cells and follicular B cells were defined as B220  CD21hi CD23lo and B220  CD21int CD23hi, respectively. The percentageQuong et al. 1109
in the follicular compartment (Fig. 6, C and E). On the
other hand, Id3    splenocytes showed a complementary
phenotype with decreased percentages of marginal zone B
cells relative to wild-type splenic B cells (Fig. 6, D and E).
The data also indicate that CD21 expression in B cells is
regulated by E-protein activity. CD21 levels were in-
creased in E2A    B cells (Fig. 6 C). In contrast, in Id3   
B cell CD21 levels were significantly decreased (Fig. 6 D).
To confirm that the perturbed CD21hi CD23lo marginal
zone compartments were genuine marginal zone B cells,
splenocytes were further analyzed for the expression of two
additional marginal zone markers, CD1 and CD9. Indeed,
both E2A    and Id3    marginal zone B cells expressed
high levels of CD1 and CD9 (Fig. 6, C and D, and not de-
picted). Although the T1 and T2 populations appeared
normal in E2A    splenocytes, the fraction of T2 positive
cells was significantly altered in Id3    splenic B cells (Fig.
6, C and D). Together, the data reveal that E-protein levels
play a key role in promoting B lineage maturation. Rela-
tive low levels of E2A promote differentiation toward the
marginal zone phenotype, whereas loss of Id3 expression
affects development at the T2 cell stage and perturbs devel-
opment toward the marginal zone B cell.
Discussion
E2A in Developing B Cells. Previous studies have dem-
onstrated a key role for E2A proteins at the earliest stages
of B cell development and before or at the stage of IgH
DJ rearrangement (14, 15). Here, we have analyzed E-pro-
tein activity beyond the pro–B cell stage. We demonstrate
that E47 protein levels are expressed at high levels in
pro–B cells, but decline upon maturing through the
pre-BCR checkpoint. E47 levels are increased again at
the pre–B cell stage and continue to be high until the cells
reach the mature B cell stage. Previous studies have de-
scribed E47 expression in B lineage development that is
clearly different from the results obtained in our work
(29). Relative high levels of E47 expression were detected
in pre–B cells, whereas in immature B and mature B lin-
eage cells, E47 protein levels were barely detectable by
immunofluorescent staining (29). Additionally, mixtures
of populations were used to assess the level of E47 by
Western blotting (29). The ability to measure E47 expres-
sion using a monoclonal antibody with specificity for E47
and intracellular staining has allowed us to more precisely
determine E47 protein levels at specific stages during B
lineage maturation.
Our studies also demonstrate that receptor editing and
developmental progression requires the activities of E2A
proteins. Specifically, IgL secondary rearrangements in
E2A    mice are virtually absent, likely in part due to sig-
nificant lower levels of RAG1 transcripts. Recent observa-
tions have indicated that E2A binding sites are present in an
enhancer element that controls the expression of RAG in
developing B cells (37). Interestingly, deletion of this en-
hancer resulted in significant decreases in RAG1 transcript
levels, whereas RAG2 levels were only slightly affected,
similar to the data described here (37). Thus, it is likely that
E2A proteins contribute to receptor editing by directly
modulating RAG expression (Fig. 7). Finally, our observa-
tions indicate that the differentiation fate of follicular versus
marginal zone B cells is affected by the activities of E2A
and Id3. Together, it appears that E-proteins act at multiple
stages to promote proper B lineage development.
E2A at the Pre-BCR Checkpoint. Our data indicate that
B cells begin to express high levels of E47 at a stage in
which their developmental potential becomes restricted to-
ward a B cell fate. The pattern of E47 expression is consis-
tent with the phenotype of E2A-deficient B cells, which
are blocked in their development before the onset of IgH
DJ rearrangement (14, 15). E47 levels decline once a pre-
BCR has formed but increase again in small resting pre–B
cells and remain high at the immature B cell stage. This ex-
pression pattern shows similarities with that observed in
thymocyte development (25). During thymocyte matura-
tion, E47 levels increase upon commitment to the T cell
lineage and decline beyond the pre-TCR checkpoint, sim-
ilar to the pro–B cell compartment as documented here.
However, we note there are also significant differences.
E47 levels remain low beyond the pre-TCR checkpoint
(25). On the other hand, E47 levels are elevated beyond
the pre-BCR checkpoint. We also note that the expression
pattern of Id3 also shows similarities in developing B and T
lineage cells. Id3 levels increase upon pre-TCR–mediated
signaling (25, 38). Signals emanating from the pre-BCR
also induce Id3 transcription (39). Thus, the pre-BCR and
pre-TCR checkpoints act similarly to modulate E47 and
Id3 expression.
What is the role of E-proteins in early T and B lineage
development? In developing thymocytes, E2A activity is
required to activate TCR   chain V(D)J gene rearrange-
ment and to regulate RAG2 gene expression (40 and un-
published data). In vitro studies have demonstrated that in
developing B cells, the E-proteins have the ability to pro-
mote IgH DJ rearrangement and to regulate RAG gene ex-
of each gated population is shown. The top histogram shows CD1 expression on MZ B gated cells from E2A wild-type (shaded area) and E2A /  (solid
line) mice as shown. For reference, the dotted line shows CD1 expression on B220  gated cells. MZ B cells express higher levels of CD1 relative to
follicular B cells. The lower histogram shows CD21 expression on B220  cells from E2A wild-type (shaded area) versus E2A    (solid line) splenocytes.
(bottom) Dot plots indicate flow cytometric analysis of T1 and T2 transitional B cell populations. T1 and T2 cells are defined as B220 CD23 CD21 /lo
IgMhi and B220 CD23 CD21hi IgMhi, respectively. Because CD21 levels are modulated by E-protein activity, the median change in overall B cell
CD21 levels was taken into account when gating the T2 population to reflect the proportion of CD21hi cells. This was consistent with T2 estimates
using the alternative markers IgM and IgD. Numbers indicate the percentage of the B220  population. (D) Analysis of Id3 wild-type and Id3    spleno-
cytes as described in C. (E) Individual experiments showing percentages of transitional and mature B cell populations as shown in A and B. (right) Percentages
of marginal zone (MZ) and follicular (Fo) B populations as shown in C and D.E-Proteins Regulate B Cell Maturation 1110
pression (22, 23). Thus, in both B and T lineage cells, the
E2A proteins regulate distinct aspects of antigen receptor
assembly. Finally, in developing thymocytes, high levels of
E47 prevent developmental progression beyond the pre-
TCR checkpoint (25). Although it remains to be proven, it
is conceivable that, given the expression pattern of E47 and
Id3, the E-proteins also enforce developmental arrest at the
pro–B cell stage.
E2A at the Immature B Cell Stage. The data presented here
show that in the pre–B and immature B cell compartments,
E47 expression is increased to levels comparable to that of
pro–B cells. What is the role of the E2A proteins at the
pre–B and immature B cell stages? E12 and E47 were orig-
inally identified as factors that bind to sites present in the
Ig  enhancer (41). The E2A proteins have also been shown
to promote Ig  VJ rearrangement in nonlymphoid cells
(23, 33). Here, we show that in E2A heterozygous mice, B
cells that carry an autoreactive receptor fail to undergo effi-
cient secondary Ig gene rearrangement. Our observations
indicate that RAG gene expression is perturbed in E2A   
B cells. We also demonstrate that secondary Ig gene rear-
rangements, including RS deletion, are affected in E2A   
B cells. Consistent with a direct involvement of E2A in
secondary gene rearrangement, we demonstrate here that
the E2A proteins have the ability to induce RS deletion in
nonlymphoid cells. Thus, it is likely that the E2A proteins
have a direct role in regulating recombinase activity in re-
sponse to self-antigen. However, we note that we cannot
exclude a role for E2A in promoting cell survival at the
stage in which the immature B cell is undergoing receptor
editing. Previous studies have demonstrated that lower lev-
els of E2A affect B cell survival (21). Consistent with these
observations, we noticed that E2A    B cells expressing the
3-83 BCR showed a significant decrease in viability in
vitro (unpublished data). Together, we favor a model in
which the E2A proteins play multiple roles in immature B
cells that express an autoreactive BCR (Fig. 7). They are
required to allow B cell survival and to directly regulate
RAG gene expression, Ig gene rearrangement, and RS de-
letion in response to self-antigen (Fig. 7).
E2A and the Developmental Progression of Immature B
Cells. Our findings indicate that E47 expression declines
in the transitional B cell populations. E47 levels in periph-
eral B cells further decline upon maturing into the
IgMlo IgD  cells. As aforementioned, high levels of E47
allow immature B cells to undergo receptor editing. We
would like to consider a model in which high levels of
E47 enforce the developmental block at this stage (Fig. 7).
In such a model, E47 levels remain high until a BCR has
formed that lacks the ability to recognize self-antigen.
High levels of E47 would ensure that RAG levels remain
high and that the Ig  locus continues to be accessible to
the recombination machinery. In the absence of signaling
mediated by self-antigen, E47 levels would eventually de-
cline and promote developmental progression. We note
that such a scenario is reminiscent of that observed in thy-
mocyte development, where E47 protein levels decline
during thymocyte positive selection and Id3 levels increase
(25). Consequently, Id3 deficiency results in a block in
thymocyte maturation and defects in E2A lead to acceler-
ated positive selection (24, 42). Thus, the strategies that
have evolved to regulate developmental progression at dis-
tinct checkpoints may be conserved in both the B and T
cell lineages.
E2A and Id3 and Follicular versus Marginal Zone B Cell De-
velopment. Our observations also indicate that in E2A   
mice the proportion of marginal zone B cells is increased
with a concomitant decrease in the proportion of follicular
B cells. On the other hand, Id3-deficient B cells exhibit a
decrease in the fraction of marginal zone B cells. The ab-
normalities in the fraction of marginal zone and follicular B
cells in E2A and Id3-deficient mice can be caused by either
a defect in lineage commitment or alternatively abnormal
maintenance of marginal zone B cells. A defect in mainte-
nance cannot be excluded because E-protein activity has
been demonstrated to regulate B cell survival and prolifera-
tion (21). However, because the changes in the proportion
of marginal zone B cells are accompanied by changes in the
proportion of follicular B cells, we favor a model in which
E2A and Id3 proteins regulate marginal zone versus follicu-
lar B cell development (Fig. 7). In such a scenario, high
levels of E2A would facilitate development toward the fol-
Figure 7. Model indicating the potential roles of E-proteins during B
cell maturation.Quong et al. 1111
licular cell fate, whereas Id3 activity would contribute to
the differentiation of marginal zone B cells (Fig. 7).
Marginal zone B cell development is also severely af-
fected in Aiolos, CD19, Pyk-2 kinase, and RBP-J null mu-
tant mice (43). The loss of marginal zone B cells in CD19
and Aiolos mutant mice was explained by abnormalities in
chemotactic migration or by hypersensitive BCR-mediated
signaling (43, 44). Because RBP-J–deficient B cells show
an increase in follicular B cells and a concomitant decline of
marginal zone B cells, it was proposed that Notch signaling
regulates cell fate determination of marginal zone B cells
(45). The abnormalities in marginal zone and follicular B
cells in E2A and Id3-deficient mice are similar to that de-
scribed for the RBP-J deficiency. This raises the intriguing
question as to whether Notch-mediated signaling regulates
E-protein activity. Previous studies have demonstrated that
E47 activity is regulated by Notch signaling by modulating
transactivation or alternatively protein stability (46, 47).
Because ras signaling regulates Id3 transcription, it is con-
ceivable that Pyk-2 regulates marginal zone B cell develop-
ment by modulating Id3 gene expression (34, 48). It will be
important to establish if Notch and/or Pyk2 signaling in de-
veloping B cells regulate E47 and Id3 levels to promote fol-
licular versus marginal zone B cell development.
We thank I. Engel and C. Sayegh for carefully reading the manu-
script. We thank Dr. M. Nussenzweig for providing us with RAG-
GFP mice. 
This work was supported by grants from the National Institutes of
Health to D. Nemazee and C. Murre. M. Quong and R. Rivera were
supported by training grants from the National Institutes of Health.
Submitted: 15 July 2003
Accepted: 4 March 2004
References
1. Alt, F.W., G.D. Yancopoulos, T.K. Blackwell, C. Wood, E.
Thomas, M. Boss, R. Coffman, N. Rosenberg, S. Tonegawa,
and D. Baltimore. 1984. Ordered rearrangement of immuno-
globulin heavy chain variable region segments. EMBO J.
3:1209–1219.
2. Rajewsky, K. 1996. Clonal selection and learning in the anti-
body system. Nature. 381:751–758.
3. Cedar, H., and Y. Bergman. Developmental regulation of
immune system gene rearrangement. 1999. Curr. Opin. Im-
munol. 11:64–69.
4. Nussenzweig, M.C., A.C. Shaw, E. Sinn, D.B. Danner,
H.C. Hohnes, C. Morse III, and P. Leder. 1988. Allelic ex-
clusion in transgenic mice that express the membrane form of
immunoglobulin  . Science. 236:816–819.
5. Manz, J., K. Denis, O. Witte, R. Brinster, and U. Storb.
1988. Feedback inhibition of immunoglobulin gene rear-
rangement by membrane but not by secreted   heavy chains.
J. Exp. Med. 168:1363–1381.
6. Sleckman, B.P., J.R. Gorman, and F.W. Alt. 1996. Accessibil-
ity control of antigen-receptor variable-region gene assembly:
role of cis-acting element. Annu. Rev. Immunol. 14:459–481.
7. Goodnow, C.C., J. Crosbie, S. Adelstein, T.B. Lavoie, S.J.
Smith-Gill, R.A. Brink, H. Pritchard-Briscoe, J.S. Wother-
spoon, R.H. Loblay, and K. Raphale. 1988. Altered immu-
noglobulin expression and functional silencing of self-reactive
B lymphocytes in transgenic mice. Nature. 334:676–682.
8. Nemazee, D.A., and K. Burki. 1989. Clonal deletion of B
lymphocytes in a transgenic mouse bearing anti-MHC class I
antibody genes. Nature. 337:562–566.
9. Gay, D., T. Saunders, S. Camper, and M. Weigert. 1993.
Receptor editing: an approach by autoreactive B cells to es-
cape tolerance. J. Exp. Med. 177:999–1008.
10. Tiegs, S.L., D.M. Russell, and D. Nemazee. 1993. Receptor
editing in self-reactive bone marrow B cells. J. Exp. Med.
177:1009–1020.
11. Radic, M.Z., J. Erikson, S. Litwin, and M. Weigert. 1993. B
lymphocytes may escape tolerance by revising their antigen
receptors. J. Exp. Med. 177:1165–1173.
12. Casellas, R., T. Shih, M. Kleinewietfeld, J. Rakonjac, D.
Nemazee, K. Rajewsky, and M.C. Nussenzweig. 2001.
Contribution of receptor editing to the antibody repertoire.
Science. 291:1541–1544.
13. Melamed, D., R.J. Benschop, J.C. Cambier, and D. Nem-
azee. 1998. Developmental regulation of B lymphocyte im-
mune tolerance compartmentalizes clonal selection from re-
ceptor selection. Cell. 92:173–182.
14. Zhuang, Y., P. Soriano, and H. Weintraub. 1994. The helix-
loop-helix gene E2A is required for B cell formation. Cell.
79:875–884.
15. Bain, G., E. Robanus Maandag, D. Izon, D. Armsen, A.
Kruisbeek, B.C. Weintraub, I. Krop, M.S. Schlissel, A.
Feeney, M. van Roon, M. van der Valk, H.P.J. te Riele,
A. Berns, and C. Murre. 1994. E2A proteins are required for
proper B cell development and initiation of immunoglobulin
gene rearrangements. Cell. 79:885–892.
16. Urbanek, P., Z. Wang, I. Fetka, E.F. Wagner, and M. Buss-
linger. 1994. Complete block of early B cell differentiation
and altered patterning of the posterior midbrain in mice lack-
ing Pax5/BSAP. Cell. 79:901–912.
17. Lin, H., and R. Grosschedl. 1995. Failure of B-cell differen-
tiation in mice lacking the transcription factor EBF. Nature.
376:263–267.
18. Engel, I., and C. Murre. 2001. The function of E- and Id
proteins in lymphocyte development. Nat. Rev. Immunol.
1:193–200.
19. O’Riordan, M., and R. Grosschedl. 1999. Coordinate regu-
lation of B cell differentiation by the transcription factors
EBF and E2A. Immunity. 11:21–31.
20. Kee, B.L., and C. Murre. 1998. Induction of early B cell factor
(EBF) and multiple B lineage genes by the basic helix-loop-
helix transcription factor E12. J. Exp. Med. 188:699–713.
21. Kee, B.L., R.R. Rivera, and C. Murre. 2001. Id3 inhibits B
lymphocyte progenitor growth and survival in response to
TGF- . Nat. Immun. 2:242–247.
22. Schlissel, M., A. Voronova, and D. Baltimore. 1991. Helix-
loop-helix transcription factor E47 activates germ-line im-
munoglobulin heavy-chain gene transcription and rearrange-
ment in a pre-T-cell line. Genes Dev. 5:1367–1371.
23. Romanow, W., A.W. Langerak, P. Goebel, I.L.M. Wovers-
Tettero, J.J.M. van Dongen, A.J. Feeney, and C. Murre.
2000. E2A and EBF act in synergy with the V(D)J recombi-
nase to generate a diverse immunoglobulin repertoire in
nonlymphoid cells. Mol. Cell. 5:343–553.
24. Rivera, R.R., C.P. Johns, J. Quan, R.S. Johnson, and
Murre, C. 2000. Thymocyte selection is regulated by the he-
lix-loop-helix inhibitor protein, Id3. Immunity. 12:17–26.
25. Engel, I., C. Johns, G. Bain, R.R. Rivera, and C. Murre.E-Proteins Regulate B Cell Maturation 1112
2001. Early thymocyte development is regulated by modula-
tion of E2A protein activity. J. Exp. Med. 194:733–745.
26. Schlissel, M.S., and D. Baltimore. 1989. Activation of immu-
nolobulin kappa gene rearrangement correlates with induction
of germline kappa gene transcription. Cell. 58:1001–1007.
27. Engel, H., A. Rolink, and S. Weiss. 1999. B cells are pro-
grammed to activate kappa and lambda for rearrangement at
consecutive developmental stages. Eur. J. Immunol. 29:2167–
2176.
28. Pongers-Willemse, M.J., O.J. Verhagen, G.J. Tibbe, A.J.
Wijkhuis, V. de Haas, E. Roovers, C.E. van der Schoot, and
J.J. van Dongen. 1998. Real-time quantitative PCR for the
detection of minimal residual disease in acute lymphoblastic
leukemia using junctional region specific TaqMan probes.
Leukemia. 12:2006–2014.
29. Herblot, S., P.D. Aplan, and T. Hoang. 2002. Gradient of E2A
activity in B cell development. Mol. Cell. Biol. 22:886–900.
30. Bain, G., S. Gruenwald, and C. Murre. 1993. E2A and E2-2
are subunits of B-cell-specific E2-box DNA-binding pro-
teins. Mol. Cell. Biol. 13:3522–3529.
31. Shen, C.P., and T. Kadesch. 1995. B-cell-specific DNA bind-
ing by an E47 homodimer. Mol. Cell. Biol. 15:4518-4524.
32. Greenbaum, S., and Y. Zhuang. 2002. Identification of E2A
target genes in B lymphocyte development by using a gene
tagging-based chromatin immunoprecipitation system. Proc.
Natl. Acad. Sci. USA. 99:15030–15035.
33. Goebel, P., N. Janney, J.R. Valenzuela, W.J. Romanow, C.
Murre, and A. Feeney. 2001. Localized gene-specific induc-
tion of accessibility to V(D)J recombination induced by E2A
and EBF in nonlymphoid cells. J. Exp. Med. 194:645–656.
34. Yu, W., H. Nagaoka, M. Jankovic, Z. Misulovin, H. Suh, A.
Rolink, F. Melchers, E. Meffre, and M.C. Nussenzweig.
1999. Continued RAG expression in late stages of B cell de-
velopment and no apparent re-induction after immunization.
Nature. 400:682–687.
35. Xu, Y., L. Davidson, F.W. Alt, and D. Baltimore. 1996. De-
letion of the Ig  light chain intronic enhancer/matrix attach-
ment region impairs but does not abolish V J  rearrange-
ment. Immunity. 4:377–385.
36. Siminovitch, K.A., A. Bakhshi, P. Goldman, and S.J. Kors-
meyer. 1985. A uniform deleting element mediates the loss of
kappa genes in human B cells. Nature. 316:260–262.
37. Hau, L, J. Lauring, H. Liang, S. Greenbaum, D. Cado, Y.
Zhuang, and M.S. Schlissel. 2003. A conserved transcrip-
tional enhancer regulates RAG gene expression in develop-
ing B cells. Immunity. 19:105–117.
38. Bain, G., C.B. Cravatt, C. Loomans, J. Alberola-Ila, S.M.
Hedrick, and C. Murre. 2001. Regulation of the helix-loop-
helix proteins, E2A and Id3, by the Ras-ERK MAPK cas-
cade. Nat. Immun. 2:165–171.
39. Schebesta, M., P.L. Pfeffer, and M. Busslinger. 2002. Control
of pre-BCR signaling by Pax-5 dependent activation of the
BLNK gene. Immunity. 17:473–485.
40. Barndt, R.J., M. Dai, and Y. Zhuang. 2000. Functions of
E2A/HEB heterodimers in T-cell development revealed by a
dominant negative mutation of HEB. Mol. Cell. Biol. 20:
6677–6685.
41. Murre, C., P.S. McCaw, and D. Baltimore. 1989. A new
DNA binding and dimerization motif in immunoglobulin
enhancer, daughterless, MyoD and myc proteins. Cell. 56:
777–783.
42. Bain, G., M.W. Quong, R.S. Soloff, S.M. Hedrick, and C.
Murre. 1999. Thymocyte maturation is regulated by the ac-
tivity of the helix-loop-helix protein, E47. J. Exp. Med. 190:
1605–616.
43. Martin, F., and J.F. Kearney. 2002. Marginal zone B cells.
Nat. Rev. Immunol. 2:323–335.
44. Wang, J.H., N. Avitahl, A. Cariappa, C. Friedrich, T. Ikeda,
A. Renold, K. Andrikopoulos, L. Liang, S. Pillai, B.A. Mor-
gan, and K. Georgopoulos. 1998. Aiolos regulates B cell acti-
vation and maturation to effector state. Immunity. 9:543–553.
45. Tanigaki, K., H. Han, N. Yamamoto, K. Tashiro, M. Ike-
gawa, K. Kuroda, A. Susuki, T. Nakano, and T. Honjo.
2002. Notch-RBP-J signaling is involved in cell fate deter-
mination of marginal zone B cells. Nat. Immun. 3:443–450.
46. Ordentlich, P., A. Lin, C.P. Shen, C. Blaumueller, K. Mat-
suno, S. Artavanis-Tsakonas, and T. Kadesch. 1998. Notch
inhibition of E47 supports the existence of a novel signaling
pathway. Mol. Cell. Biol. 18:2230–2239.
47. Nie, L., M. Xu, A. Vladimirova, and X.H. Sun. 2003.
Notch-induced E2A ubiquitination and activities. EMBO J.
3:5780–5792.
48. Guinamard, R., M. Okigaki, J. Schlessinger, and J.V.
Ravetch. 2000. Absence of marginal zone B cells in Pyk-2-
deficient mice defines their role in the humoral response.
Nat. Immun. 1:31–36.